Ed Mathers
Partner·New Enterprise Associates
Ed Mathers is a Partner on NEA’s healthcare team. NEA says he has been at the firm since 2008 and focuses on biotechnology and specialty pharmaceuticals investments. His official profile lists seed/early and growth as stages and includes healthcare as his sector. Before NEA, he served as EVP of Corporate Development and Venture at MedImmune, helped execute its sale to AstraZeneca, held licensing and acquisition roles at Inhale Therapeutic Systems, and spent 15 years at Glaxo Wellcome. He describes his healthcare interests as cutting-edge technologies across gene therapy, nonviral gene therapy, RNA editing, and immunology and inflammation.
See the rest of Ed Mathers's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.